Literature DB >> 1691222

Expression and ontogeny of CD2 on murine B cells.

J Sen1, N Rosenberg, S J Burakoff.   

Abstract

Expression of CD2 on developing and mature murine B cells was examined by using an antipeptide antiserum (L50). Most Ig-bearing splenic B cells were found to express CD2. Anti-CD5 and anti-B220 mAb divided the peritoneal B cells into two populations expressing high and low levels of these proteins; both populations were found to express uniform levels of CD2. Abelson murine leukemia virus-transformed pre-B cell lines derived from fetal liver and adult bone marrow were analyzed to delineate the ontogeny of CD2 in the B cell lineage. The results show that onset of CD2 expression correlates with the presence of cytoplasmic mu-chain. Therefore, the earliest CD2+ pre-B cell in the developing B cell population appears to be the classical pre-B cell.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691222

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  In senescence, age-associated B cells secrete TNFα and inhibit survival of B-cell precursors.

Authors:  Michelle Ratliff; Sarah Alter; Daniela Frasca; Bonnie B Blomberg; Richard L Riley
Journal:  Aging Cell       Date:  2013-04       Impact factor: 9.304

2.  Compound haploinsufficiencies of Ebf1 and Runx1 genes impede B cell lineage progression.

Authors:  Kara Lukin; Scott Fields; Desiree Lopez; Marie Cherrier; Kristina Ternyak; Julita Ramírez; Ann J Feeney; James Hagman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

3.  Effect of transgenic overexpression of FLIP on lymphocytes on development and resolution of experimental autoimmune thyroiditis.

Authors:  Yujiang Fang; Gordon C Sharp; Helen Braley-Mullen
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

Review 4.  Chromodomain helicase DNA-binding 4 (CHD4) regulates early B cell identity and V(D)J recombination.

Authors:  James R Hagman; Tessa Arends; Curtis Laborda; Jennifer R Knapp; Laura Harmacek; Brian P O'Connor
Journal:  Immunol Rev       Date:  2021-12-20       Impact factor: 10.983

5.  Expression of CD2 on porcine B lymphocytes.

Authors:  J Sinkora; Z Reháková; M Sinkora; B Cukrowska; H Tlaskalová-Hogenová; A T Bianchi; B De Geus
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

6.  Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.

Authors:  H R Rodewald; K Awad; P Moingeon; L D'Adamio; D Rabinowitz; Y Shinkai; F W Alt; E L Reinherz
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

7.  Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice.

Authors:  J Wu; T Zhou; J Zhang; J He; W C Gause; J D Mountz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

8.  Anti-CD2 antibodies induce T cell unresponsiveness in vivo.

Authors:  B Gückel; C Berek; M Lutz; P Altevogt; V Schirrmacher; B A Kyewski
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

9.  In aged mice, low surrogate light chain promotes pro-B-cell apoptotic resistance, compromises the PreBCR checkpoint, and favors generation of autoreactive, phosphorylcholine-specific B cells.

Authors:  Michelle Ratliff; Sarah Alter; Kelly McAvoy; Daniela Frasca; Jacqueline A Wright; Sandra S Zinkel; Wasif N Khan; Bonnie B Blomberg; Richard L Riley
Journal:  Aging Cell       Date:  2015-02-27       Impact factor: 9.304

10.  Dissection of progenitor compartments resolves developmental trajectories in B-lymphopoiesis.

Authors:  Christina T Jensen; Josefine Åhsberg; Mikael N E Sommarin; Tobias Strid; Rajesh Somasundaram; Kazuki Okuyama; Jonas Ungerbäck; Jussi Kupari; Matti S Airaksinen; Stefan Lang; David Bryder; Shamit Soneji; Göran Karlsson; Mikael Sigvardsson
Journal:  J Exp Med       Date:  2018-06-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.